ARDS, HUMAN
Clinical trials for ARDS, HUMAN explained in plain language.
Never miss a new study
Get alerted when new ARDS, HUMAN trials appear
Sign up with your email to follow new studies for ARDS, HUMAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Stem cells tested to heal COVID-Damaged lungs
Disease control TerminatedThis early-stage study aimed to test the safety of stem cell therapy for patients recovering from severe COVID-19 lung damage (ARDS). The treatment involved giving patients stem cells from donors to help reduce inflammation and promote healing. The study was withdrawn before any …
Matched conditions: ARDS, HUMAN
Phase: PHASE1 • Sponsor: BioCardia, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Experimental lung wash aims to save ventilated COVID patients
Disease control TerminatedThis study aimed to test whether putting a medication called T3 directly into the lungs could help people with severe COVID-19 who were on a ventilator. It planned to enroll patients with life-threatening breathing failure (ARDS) to see if the treatment could reduce dangerous flu…
Matched conditions: ARDS, HUMAN
Phase: PHASE2 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC